CIDALTEX® ANTIVIRAL MASKS DURING THE COVID-19 PANDEMIC
Prof. bernard Martel (University of Lille, France) showed how the new cyclodextrin-based mask was developed from the in-lab optimization to
Tag: Covid-19
Buccal administration of remdesivir – still far from reality
As remdesivir, the first FDA-approved drug for SARS-CoV-2 infection, can be used only for hospitalized patients due to intravenous administration,
Remdesivir administration for Japanese COVID-19 patients undergoing maintenance hemodialysis: a retrospective observation with six case reports
The mortality rate of novel coronaviral disease (COVID-19) patients undergoing dialysis is considerably higher than that of patients with normal
FDA Approves First COVID-19 Treatment for Young Children
The press release was published on the U.S. Food and Drug Administration website: On Apr. 26, 2022, the U.S. Food
Use of Antivirals in SARS-CoV-2 Infection. Critical Review of the Role of Remdesivir
The aim of this report is to review the literature and shed light on the uncertainties surrounding the use of
CycloLab awarded by 2021 Innovation Grand Prize
The Hungarian Association of Innovation awarded CycloLab with this prestigious prize due to its meaningful and very profitable innovation concerning
Nature News on Covid drugs: overview and new trends
Over the past two years, the ACTIV programme, run by the US National Institutes of Health (NIH), has included more
Comparative evaluation of HPBCD-adjuvanted booster vaccine
Background: Although the three vaccines against coronavirus disease 2019 (Covid-19) that have received emergency use authorization in the United States are
Scientists are racing to develop more COVID antivirals
Nature News evaluated antiviral drugs developed for the treatment of Covid-19. Clinical-trial data showed that molnupiravir, developed by the pharmaceutical
Spike Ferritin Nanoparticle Covid-19 vaccine
The US Army has recently developed a SARS-CoV-2 sub-unit vaccine based on a ferritin nanoparticle platform that displays a pre-fusion